Log in
OTCMKTS:KHRNF

Khiron Life Sciences Stock Forecast, Price & News

$0.32
-0.04 (-11.24 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.31
Now: $0.32▼
$0.36
50-Day Range
$0.28
MA: $0.33▼
$0.42
52-Week Range
$0.22
Now: $0.32▼
$0.90
Volume1.33 million shs
Average Volume206,902 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; and develops CBD-based cosmeceutical products under the Kuida brand name. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.

Beat the Market (BTM) Rank™

Analyst Opinion: 3.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.44 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:KHRNF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.khiron.ca
Phone705-527-3564
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$0.32
-0.04 (-11.24 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KHRNF News and Ratings via Email

Sign-up to receive the latest news and ratings for KHRNF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Khiron Life Sciences (OTCMKTS:KHRNF) Frequently Asked Questions

How has Khiron Life Sciences' stock price been impacted by Coronavirus?

Khiron Life Sciences' stock was trading at $0.4259 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KHRNF shares have decreased by 25.8% and is now trading at $0.3160.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Khiron Life Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Khiron Life Sciences or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Khiron Life Sciences?

Wall Street analysts have given Khiron Life Sciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Khiron Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for KHRNF?

1 brokerages have issued 12-month price targets for Khiron Life Sciences' shares. Their forecasts range from $2.80 to $2.80. On average, they expect Khiron Life Sciences' share price to reach $2.80 in the next year. This suggests a possible upside of 786.1% from the stock's current price.
View analysts' price targets for Khiron Life Sciences.

Are investors shorting Khiron Life Sciences?

Khiron Life Sciences saw a increase in short interest in November. As of November 15th, there was short interest totaling 312,500 shares, an increase of 83.8% from the October 31st total of 170,000 shares. Based on an average daily volume of 565,200 shares, the days-to-cover ratio is presently 0.6 days.
View Khiron Life Sciences' Short Interest.

Who are some of Khiron Life Sciences' key competitors?

Some companies that are related to Khiron Life Sciences include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group Holdings Limited (AGH.AX) (AGH), Applied Biosciences (APPB), AusCann Group Holdings Ltd (AC8.AX) (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics Limited (CP1.AX) (CP1).
View all competitors.

Who are Khiron Life Sciences' key executives?

Khiron Life Sciences' management team includes the following people:
  • Mr. Alvaro Francisco Torres, Co-Founder, CEO & Director (Age 41)
  • Mr. Vicente Fox, Strategic Advisor & Director (Age 77)
  • Mr. Andres Galofre, Co-Founder & VP of Bus. Devel.s (Age 38)
  • Mr. Joel Friedman, Chief Financial Officer
  • Mr. Manuel Buendia, VP of Operations
  • Mr. Matt Murphy, VP of Compliance (Age 58)
  • Ms. Livia M. Maduri, Gen. Counsel & Corp. Sec.
  • Jon Packer, VP of Communications
  • Mr. Luis Chavez, Country Mang. of Mexico
  • Mr. Marco Algorta, Country Mang. of Uruguay

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Khiron Life Sciences' stock price today?

One share of KHRNF stock can currently be purchased for approximately $0.32.

What is Khiron Life Sciences' official website?

The official website for Khiron Life Sciences is www.khiron.ca.

How can I contact Khiron Life Sciences?

The company can be reached via phone at 705-527-3564.

This page was last updated on 12/2/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.